TRILのニュース
Trillium Therapeutics (NASDAQ:TRIL) Downgraded to “Hold” at Benchmark 2021/11/17 12:20:41 Dakota Financial News
Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) was downgraded by investment analysts at Benchmark from a “buy” rating to a “hold” rating in a report released on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the company. Bloom Burton began coverage on Trillium Therapeutics in a report on Friday, October 1st. They issued […]
Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer 2021/11/17 00:29:10 Seeking Alpha
Is Now The Time To Buy Trillium Therapeutics Inc. (NASDAQ: TRIL) Stock? 2021/11/16 19:00:00 Stocks Register
Trillium Therapeutics Inc. (NASDAQ:TRIL) price is hovering higher on Tuesday, November 16, jumping 2.64% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Trillium Therapeutics (NASDAQ:TRIL) Sees Strong Trading Volume 2021/11/16 17:42:42 Transcript Daily
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) shares saw unusually-strong trading volume on Tuesday . Approximately 661,216 shares were traded during trading, a decline of 62% from the previous sessions volume of 1,755,849 shares.The stock last traded at $18.39 and had previously closed at $17.97. A number of equities research analysts recently commented on TRIL shares. Craig []
Trillium Therapeutics (NASDAQ:TRIL) Downgraded to “Hold” at Benchmark 2021/11/17 12:20:41 Dakota Financial News
Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) was downgraded by investment analysts at Benchmark from a “buy” rating to a “hold” rating in a report released on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the company. Bloom Burton began coverage on Trillium Therapeutics in a report on Friday, October 1st. They issued […]
Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer 2021/11/17 00:29:10 Seeking Alpha
Is Now The Time To Buy Trillium Therapeutics Inc. (NASDAQ: TRIL) Stock? 2021/11/16 19:00:00 Stocks Register
Trillium Therapeutics Inc. (NASDAQ:TRIL) price is hovering higher on Tuesday, November 16, jumping 2.64% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Trillium Therapeutics (NASDAQ:TRIL) Sees Strong Trading Volume 2021/11/16 17:42:42 Transcript Daily
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) shares saw unusually-strong trading volume on Tuesday . Approximately 661,216 shares were traded during trading, a decline of 62% from the previous sessions volume of 1,755,849 shares.The stock last traded at $18.39 and had previously closed at $17.97. A number of equities research analysts recently commented on TRIL shares. Craig []
Trillium Therapeutics (NASDAQ:TRIL) Downgraded to “Hold” at Benchmark 2021/11/17 12:20:41 Dakota Financial News
Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) was downgraded by investment analysts at Benchmark from a “buy” rating to a “hold” rating in a report released on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the company. Bloom Burton began coverage on Trillium Therapeutics in a report on Friday, October 1st. They issued […]
Trillium Therapeutics gets Canada, HSR approval for sale to Pfizer 2021/11/17 00:29:10 Seeking Alpha
Is Now The Time To Buy Trillium Therapeutics Inc. (NASDAQ: TRIL) Stock? 2021/11/16 19:00:00 Stocks Register
Trillium Therapeutics Inc. (NASDAQ:TRIL) price is hovering higher on Tuesday, November 16, jumping 2.64% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
Trillium Therapeutics (NASDAQ:TRIL) Sees Strong Trading Volume 2021/11/16 17:42:42 Transcript Daily
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) shares saw unusually-strong trading volume on Tuesday . Approximately 661,216 shares were traded during trading, a decline of 62% from the previous sessions volume of 1,755,849 shares.The stock last traded at $18.39 and had previously closed at $17.97. A number of equities research analysts recently commented on TRIL shares. Craig []